{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T22:25:12Z","timestamp":1787955912730,"version":"build-2784847793"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T00:00:00Z","timestamp":1623801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014857","name":"National Natural Science Foundation of China-Guangdong Joint Fund","doi-asserted-by":"publisher","award":["81502750"],"award-info":[{"award-number":["81502750"]}],"id":[{"id":"10.13039\/501100014857","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:p>Rosacea is a chronic inflammatory skin disease characterized by facial redness and bothersome symptoms. It can exert significant psychological effects and impair the quality of life of patients. To investigate the prevalence and risk predictors of anxiety and depression in rosacea patients, we conducted a cross-sectional study in an outpatient setting. Consecutive patients completed a questionnaire, which included questions on sociodemographic information and severity of signs and symptoms; they also completed the Patient Health Questionnaire and the Generalized Anxiety Disorder scale. Disease burden was assessed using Dermatology Life Quality Index (DLQI), Willing-to-Pay, and Time trade-off. Multivariate analysis was conducted to determine the risk factors for anxiety and depression. A total of 774 patients completed the survey. The prevalence of anxiety was 53.9% (95% CI: 50.4\u201357.4%) and that of depression was 58.1% (95% CI: 54.7\u201361.6%). The factors associated with anxiety were age, gender, the need to make appearances at work, severity of self-reported symptoms, the number of rosacea signs and adaptive behaviors, and disease burden. Depression was associated with younger age, more severe self-reported symptoms, more adaptive behaviors, and higher disease burden. After adjusting for demographics, the risk of anxiety or depression increased in young patients who had severe self-reported symptoms, high DLQI scores, and many adaptive behaviors. Taken together, there is a high prevalence of anxiety and depression among Chinese rosacea patients. Younger rosacea patients who have more severe self-reported symptoms and higher disease burden are prone to anxiety and depression.<\/jats:p>","DOI":"10.3389\/fpsyt.2021.659171","type":"journal-article","created":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T02:31:36Z","timestamp":1623810696000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":24,"title":["Prevalence and Risk Factors of Anxiety and Depression in Rosacea Patients: A Cross-Sectional Study in China"],"prefix":"10.3389","volume":"12","author":[{"given":"Mengting","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhili","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingxue","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,6,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1111\/bjd.16481","article-title":"Incidence and prevalence of rosacea: a systematic review and meta-analysis","volume":"179","author":"Gether","year":"2018","journal-title":"Br J Dermato."},{"key":"B2","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1111\/1346-8138.15301","article-title":"Epidemiological features of rosacea in Changsha, China: a population-based, cross-sectional study","volume":"47","author":"Li","year":"2020","journal-title":"J Dermato."},{"key":"B3","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.jaad.2017.08.037","article-title":"Standard classification and pathophysiology of rosacea: the 2017 update by the National Rosacea Society Expert Committee","volume":"78","author":"Gallo","year":"2018","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1016\/j.jaad.2020.01.077","article-title":"standard management options for rosacea: the 2019 update by the national rosacea society expert committee","volume":"82","author":"Thiboutot","year":"2020","journal-title":"Eur Acad Dermatol Venereol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"F1000","DOI":"10.12688\/f1000research.16537.1","article-title":"Recent advances in understanding and managing rosacea","volume":"7","author":"Buddenkotte","year":"2018","journal-title":"F1000Research."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.3390\/ijms17091562","article-title":"Rosacea: molecular mechanisms and management of a chronic cutaneous inflammatory condition","volume":"17","author":"Woo","year":"2016","journal-title":"Int j mol sci."},{"key":"B7","unstructured":"Rosacea Triggers Survey.2015"},{"key":"B8","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.det.2017.11.013","article-title":"Coping mechanisms and resources for patients suffering from rosacea","volume":"36","author":"Cardwell","year":"2018","journal-title":"Dermatol Clin."},{"key":"B9","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/jdv.13748","article-title":"Feelings of stigmatization in patients with rosacea","volume":"31","author":"Halioua","year":"2017","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1111\/j.1365-2133.2005.06895.x","article-title":"Comorbidity of rosacea and depression: an analysis of the national ambulatory medical care survey and national hospital ambulatory care survey\u2013outpatient department data collected by the US national center for health statistics from 1995 to 2002","volume":"153","author":"Gupta","year":"2005","journal-title":"Br J Dermato."},{"key":"B11","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.det.2017.11.005","article-title":"Psychosocial burden and other impacts of rosacea on patients' quality of life","volume":"36","author":"Oussedik","year":"2018","journal-title":"Dermatol Clin."},{"key":"B12","doi-asserted-by":"publisher","first-page":"488","DOI":"10.2340\/00015555-0716","article-title":"Subjective disease perception and symptoms of depression in relation to healthcare-seeking behaviour in patients with rosacea","volume":"89","author":"Abram","year":"2009","journal-title":"Acta Dermato-Venereol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/bjd.15780","article-title":"Experiences of rosacea and its treatment: an interpretative phenomenological analysis","volume":"178","author":"Johnston","year":"2018","journal-title":"Br J Dermato."},{"key":"B14","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s13555-015-0077-2","article-title":"Perceptions on the psychological impact of facial erythema associated with rosacea: results of international survey","volume":"5","author":"Dirschka","year":"2015","journal-title":"Dermatol Ther."},{"key":"B15","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1097\/00000441-195610000-00013","article-title":"Are-evaluation of the rosacea complex","volume":"232","author":"Beerman","year":"1956","journal-title":"Am J Med Sci."},{"key":"B16","first-page":"348","article-title":"Burden of disease: the psychosocial impact of rosacea on a patient's quality of life","volume":"6","author":"Huynh","year":"2013","journal-title":"Am Health Drug Benefits."},{"key":"B17","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","article-title":"Dermatology life quality index (DLQI)\u2013a simple practical measure for routine clinical use","volume":"19","author":"Finlay","year":"1994","journal-title":"Clin exp dermatol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1038\/jid.2012.50","article-title":"Willingness to pay in dermatology: assessment of the burden of skin diseases","volume":"132","author":"Seidler","year":"2012","journal-title":"J Invest Dermatol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1046\/j.1365-2133.2003.05156.x","article-title":"Willingness to pay and time trade-off: sensitive to changes of quality of life in psoriasis patients?","volume":"148","author":"Schiffner","year":"2003","journal-title":"Br J Dermatol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1111\/j.1365-2133.2010.09894.x","article-title":"The impact of rosacea on quality of life: effects of demographic and clinical characteristics and various treatment modalities","volume":"163","author":"Aksoy","year":"2010","journal-title":"Br J Dermatol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1111\/j.1468-3083.2012.04549.x","article-title":"Willingness to pay and quality of life in patients with rosacea","volume":"27","author":"Beikert","year":"2013","journal-title":"J Europ Acad Dermatol Venereol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1080\/13548506.2013.841968","article-title":"Symptom severity and psychological sequelae in rosacea: results of a survey","volume":"19","author":"Boehm","year":"2014","journal-title":"Psychol Health Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9\u2013validity of a brief depression severity measure","volume":"16","author":"Kroenke","year":"2001","journal-title":"J General Internal Med."},{"key":"B24","doi-asserted-by":"publisher","first-page":"E191","DOI":"10.1503\/cmaj.110829","article-title":"Optimal cut-off score for diagnosing depression with the patient health questionnaire (PHQ-9): a meta-analysis","volume":"184","author":"Manea","year":"2012","journal-title":"Canad Med Assoc J."},{"key":"B25","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s12888-019-2128-1","article-title":"Mental health of patients with adolescent idiopathic scoliosis and their parents in china: a cross-sectional survey","volume":"19","author":"Wang","year":"2019","journal-title":"BMC Psychiatry."},{"key":"B26","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s00403-013-1402-1","article-title":"Willingness to pay and quality of life in patients with atopic dermatitis","volume":"306","author":"Beikert","year":"2014","journal-title":"Arch Dermatol Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1080\/09546634.2019.1665305","article-title":"Characterizing high-burden rosacea subjects: a multivariate risk factor analysis from a global survey (vol 18, pg 1, 2019)","volume":"31","author":"Tan","year":"2020","journal-title":"J Dermatolog Treat."},{"key":"B28","unstructured":"Red Alert: Rosacea Awareness Month Highlights Potential Increased Health Risks.2016"},{"key":"B29","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.abd.2019.03.002","article-title":"Rosacea associated with increased risk of generalized anxiety disorder: a case-control study of prevalence and risk of anxiety in patients with rosacea","volume":"94","author":"Uysal","year":"2019","journal-title":"Anais Brasileiros De Dermatol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1080\/13548506.2017.1361540","article-title":"The dermatology life quality index (DLQI) and the hospital anxiety and depression (HADS) in Chinese rosacea patients","volume":"23","author":"Wu","year":"2018","journal-title":"Psychol Health Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"106178","DOI":"10.1016\/j.intimp.2019.106178","article-title":"Hydroxychloroquine is a novel therapeutic approach for rosacea","volume":"79","author":"Li","year":"2020","journal-title":"Int Immunopharmacol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"109011","DOI":"10.1016\/j.biopha.2019.109011","article-title":"Thalidomide ameliorates rosacea-like skin inflammation and suppresses NF-kappa B activation in keratinocytes","volume":"116","author":"Chen","year":"2019","journal-title":"Biomed Pharmacother."},{"key":"B33","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.bbrc.2019.10.073","article-title":"ADAMDEC1 Promotes skin inflammation in rosacea via modulating the polarization of m1 macrophages","volume":"521","author":"Liu","year":"2020","journal-title":"Biochem Biophys Res Commun."},{"key":"B34","doi-asserted-by":"publisher","first-page":"e737","DOI":"10.1111\/jdv.16576","article-title":"Prevalence, clinical characteristics and health-related quality of life of rosacea in chinese adolescents: a population-based study","volume":"34","author":"Chen","year":"2020","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"103","DOI":"10.2147\/ccid.S126850","article-title":"Psychosocial aspects of rosacea with a focus on anxiety and depression","volume":"11","author":"Heisig","year":"2018","journal-title":"Clin Cosmetic Invest Dermatol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1111\/j.1365-2133.2009.09091.x","article-title":"Willingness-to-pay and quality of life in patients with vitiligo","volume":"161","author":"Radtke","year":"2009","journal-title":"Br J Dermato."}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2021.659171\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T02:31:39Z","timestamp":1623810699000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2021.659171\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,16]]},"references-count":36,"alternative-id":["10.3389\/fpsyt.2021.659171"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2021.659171","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,16]]},"article-number":"659171"}}